Clinical Trials

Accrual Status
Limit to SWOG Trials

1030 Results

Status Trial Number Title Sort descending Activated Closed Accrual Phase Published
Closed SWOG-8900 A Phase II Pilot of VAD and VAD/Verapamil for Refractory Multiple Myeloma 5/1/1989 12/1/1991 100% Published
Closed SWOG-9107 A Phase II Pilot Study of High Dose 24-Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA for Patients with Colorectal Cancer 1/1/1993 8/1/1994 70% Published
Closed SWOG-9100 A Phase II Pilot Study of High-Dose 24 Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA in Patients with Pancreatic Adenocarcinoma 1/15/1993 8/1/1994 86% Published
Open S2005 A PHASE II RANDOMIZED STUDY COMPARING IBRUTINIB AND RITUXIMAB VS. VENETOCLAX AND RITUXIMAB IN PREVIOUSLY UNTREATED WALDENSTROM'S MACROGLOBULINEMIA (WM) /LYMPHOPLASMACYTIC LYMPHOMA (LPL) 6/24/2021 5%
Open S2104 A Phase II Randomized Trial of Postoperative Adjuvant Capecitabine and Temozolimide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors 10/14/2021 31%
Closed SWOG-9500 A Phase II Study of 7 + 3 and High Dose Ara-C Induction Therapy with Sequential High-Dose Ara-C Consolidation Therapy for Adults with De Novo Acute Myeloid Leukemia 12/15/1995 4/1/1997 100% Published
Closed SWOG-9143 A Phase II Study of Cisplatin Preceded by a 12-hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) for Patients with Untreated Malignant Mesothelioma 8/15/1992 9/15/1994 100% Published
Closed SWOG-9148 A Phase II Study of Cisplatin Preceded By A 12-Hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) For Patients with Untreated, Extensive Stage Small Cell and Non… 9/1/1992 6/1/1995 58%
Closed SWOG-8822 A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (r-IL-2) in Patients with Malignant Lymphoma 5/1/1989 6/15/1991 6%
Closed SWOG-8824 A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Advanced Renal Cell Carcinoma 5/1/1989 8/15/1991 100% Published
Closed SWOG-8830 A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Ovarian Cancer 4/1/1989 11/15/1990 10%
Closed SWOG-8832 A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Pancreatic Cancer 4/1/1989 11/15/1990 6%
Closed S9711 A Phase II Study of IL-4 in Patients with Relapsed or Refractory B Lineage Acute Lymphoblastic Leukemia. 5/15/1997 8/15/1998 10%
Closed SWOG-8735 A Phase II Study of Recombinant Human Interferon- Alpha and Recombinant Human Interferon-Gamma in Previously Untreated Patients with Chronic Myelogenous Leukemia 4/1/1988 5/15/1990 57%
Closed SWOG-8752 A Phase II Study of Recombinant Tumor Necrosis (rTNF) in Patients with Endometrial Cancer 9/15/1988 7/15/1990 17%
Closed SWOG-8806 A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Advanced Bladder Cancer (for patients not eligible for SWOG-8594) 8/15/1988 11/15/1990 25%
Closed SWOG-8808 A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Chronic Myeloid Leukemia 11/15/1989 11/15/1990 0%
Closed SWOG-8760 A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Gastric Carcinoma 6/15/1988 1/1/1990 83% Published
Closed SWOG-8743 A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients with Metastatic Colorectal Adenocarcinoma 6/15/1988 1/1/1990 71% Published
Closed SWOG-8755 A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients With Pancreatic Adeno-carcinoma 6/15/1988 1/1/1990 Published
Scroll Table